New agents for targeting egfr/her2: where are we?

被引：0
|
作者：
Cheol, Chung Hyun [1 ]
机构：
[1] Yonsei Univ, Coll Med, Yonsei Canc Ctr, Seoul, South Korea
来源：
9TH INTERNATIONAL GASTRIC CANCER CONGRESS (IGCC 2011): A GATE TO THE FUTURE OF GASTRIC CANCER TREATMENT | 2011年
关键词：
TRASTUZUMAB;
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：7 / 12
页数：6
相关论文
共 50 条
  • [1] Renal toxicity of anticancer agents targeting HER2 and EGFR
    Laura Cosmai
    Maurizio Gallieni
    Camillo Porta
    Journal of Nephrology, 2015, 28 : 647 - 657
  • [2] Renal toxicity of anticancer agents targeting HER2 and EGFR
    Cosmai, Laura
    Gallieni, Maurizio
    Porta, Camillo
    JOURNAL OF NEPHROLOGY, 2015, 28 (06) : 647 - 657
  • [3] Targeting of EGFR and HER2 with therapeutic antibodies and siRNA
    Wichmann, Henri
    Guettler, Antje
    Bache, Matthias
    Taubert, Helge
    Rot, Swetlana
    Kessler, Jacqueline
    Eckert, Alexander W.
    Kappler, Matthias
    Vordermark, Dirk
    STRAHLENTHERAPIE UND ONKOLOGIE, 2015, 191 (02) : 180 - 191
  • [4] Overcoming resistance to HER2 targeting agents
    Osborne, C. K.
    Duncan, D. L.
    Rimawi, M.
    Prat, A.
    BREAST, 2017, 32 : S3 - S4
  • [5] Targeting HER2 in prostate cancer: Where to next?
    Solit, David B.
    Rosen, Neal
    JOURNAL OF CLINICAL ONCOLOGY, 2007, 25 (03) : 241 - 243
  • [6] Novel agents that downregulate EGFR, HER2, and HER3 in parallel
    Ferreira, Renan Barroso
    Law, Mary Elizabeth
    Jahn, Stephan Christopher
    Davis, Bradley John
    Heldermon, Coy Don
    Reinhard, Mary
    Castellano, Ronald Keith
    Law, Brian Keith
    ONCOTARGET, 2015, 6 (12) : 10445 - 10459
  • [7] Targeting human EGFR 2 (HER2) in salivary gland carcinoma
    Wotman, Michael
    El-Naggar, Adel
    Ferrarotto, Renata
    EXPERT REVIEW OF ANTICANCER THERAPY, 2023, 23 (06) : 573 - 582
  • [8] Where to With HER2?
    Sledge, George W., Jr.
    CLINICAL BREAST CANCER, 2010, 10 (01) : 18 - 18
  • [9] DUAL EGFR/HER2 TARGETING STRATEGY IN TREATMENT OF PANCREATIC CANCER
    Larbouret, C.
    Gaborit, N.
    Chardes, T.
    Coehlo, M.
    Campigna, E.
    Mollevi, C.
    Mach, J. P.
    Azria, D.
    Robert, B.
    Pelegrin, A.
    ANNALS OF ONCOLOGY, 2012, 23 : 34 - 35
  • [10] Targeting HER2 Positive Breast Cancer with Chemopreventive Agents
    Wahler J.
    Suh N.
    Current Pharmacology Reports, 2015, 1 (5) : 324 - 335
12345